Evidence map›Paper›PMID 39861712›Full record

ArticlePharmaceutics2025

Production of Hydrophobic Microparticles at Safe-To-Inject Sizes for Intravascular Administration.

Francisca L Gomes, Francisco Conceição, Liliana Moreira Teixeira, Jeroen Leijten, Pascal Jonkheijm

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Francisca L GomesLaboratory of Biointerface Chemistry, Department of Molecules and Materials, Faculty of Science and Technology, Technical Medical Centre and MESA+ Institute, University of Twente, 7522NB Enschede, The Netherlands.ORCID 0000-0001-6416-0589
Francisco ConceiçãoDepartment of BioEngineering Technologies, Advanced Organ Bioengineering and Therapeutics, Faculty of Science and Technology, Technical Medical Centre, University of Twente, 7522NB Enschede, The Netherlands.ORCID 0000-0003-4587-2470
Liliana Moreira TeixeiraDepartment of BioEngineering Technologies, Advanced Organ Bioengineering and Therapeutics, Faculty of Science and Technology, Technical Medical Centre, University of Twente, 7522NB Enschede, The Netherlands.ORCID 0000-0001-5039-8369
Jeroen LeijtenLeijten Laboratory, Department of BioEngineering Technologies, Faculty of Science and Technology, Technical Medical Centre, University of Twente, 7522NB Enschede, The Netherlands.ORCID 0000-0002-8063-207X
Pascal JonkheijmLaboratory of Biointerface Chemistry, Department of Molecules and Materials, Faculty of Science and Technology, Technical Medical Centre and MESA+ Institute, University of Twente, 7522NB Enschede, The Netherlands.ORCID 0000-0001-6271-0049

Funding

Health~Holland Project LSHM19074
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

blood capillaryemulsificationinjectabilitymicroparticlespolycaprolactone

Identifiers

PMID39861712
PMCPMC11768317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.